Clinical Trials Directory

Trials / Conditions / Chickenpox

Chickenpox

23 registered clinical trials studyying Chickenpox — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Giv
NCT06806137
GlaxoSmithKlinePhase 3
RecruitingA Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mum
NCT06855160
GlaxoSmithKlinePhase 3
RecruitingA Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Child
NCT06740630
GlaxoSmithKlinePhase 3
RecruitingA Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Month
NCT06693895
GlaxoSmithKlinePhase 3
CompletedOpen Clinical Investigation to Evaluate the Effectiveness and Safety of a Topical Medical Device.
NCT05732337
Karo Pharma ABN/A
CompletedA Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compar
NCT05084508
GlaxoSmithKlinePhase 2
CompletedSafety and Immunogenicity of Skyvaricella Injection in Healthy Volunteer Vietnamese Children From 12 Months to
NCT04384016
Vietnam Military Medical UniversityPhase 4
CompletedA Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Heal
NCT02570126
GlaxoSmithKlinePhase 3
CompletedReview of Human Herpes Viruses in Burns
NCT02452229
The University of Texas Medical Branch, Galveston—
UnknownImmune Persistence After Inoculated With One-dose Freeze-Dried Live Attenuated Varicella Vaccine in Children V
NCT01982409
Changchun Changsheng Life Science and Technology Co., Ltd.Phase 4
CompletedImmunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE Vaccine
NCT01815073
Changchun Keygen Biological Products Co., Ltd.Phase 4
CompletedImmunogenicity and Safety Study of 2 Doses of Live Attenuated Varicella Vaccine
NCT01817270
Changchun Keygen Biological Products Co., Ltd.Phase 4
CompletedSafety and Immunogenicity Study of Live Attenuated Vaccine Against Varicella Without Gelatin
NCT01684072
Beijing Center for Disease Control and PreventionPhase 4
CompletedVaricella-related Hospitalizations in Turkey
NCT01887496
Eskisehir Osmangazi University—
CompletedImmune Response to Varicella-Zoster Vaccination and Infection
NCT00921999
National Institute of Allergy and Infectious Diseases (NIAID)—
CompletedHepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V2
NCT00326183
Merck Sharp & Dohme LLCPhase 4
CompletedFamciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection
NCT00098046
NovartisPhase 3
CompletedMMR and Varicella Vaccine in Premature Infants
NCT00156559
University of Rochester—
WithdrawnThe Safety and Effectiveness of Valacyclovir HCl in the Treatment of Herpes Simplex or Varicella/Zoster Infect
NCT00001054
National Institute of Allergy and Infectious Diseases (NIAID)Phase 1
CompletedA Comparison of 882C87 Versus Acyclovir in the Treatment of Herpes Zoster in Patients With Weakened Immune Sys
NCT00002315
Glaxo WellcomePhase 3
CompletedComparison of Brovavir Versus Acyclovir in the Treatment of Herpes in HIV-Infected Patients
NCT00000953
National Institute of Allergy and Infectious Diseases (NIAID)Phase 2
CompletedA Study of BV-araU in the Treatment of Varicella-Zoster Viral Disease (VZV) in HIV-Infected Children Who Have
NCT00002358
Bristol-Myers SquibbPhase 3
CompletedUse of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Ha
NCT00001125
National Institute of Allergy and Infectious Diseases (NIAID)Phase 1